|
|
|
| Analysis of characteristics of 60 cases of Risperidone-induced extrapyramidal side effect |
| ZHANG Ming-hui ZHANG Hong-wei CHEN Jin-lan HUANG Wen-can XUE Xin-jie ZHUANG Shu-li |
| Department of Pharmacy,Mental Hospital of Guangzhou Civil Affairs Bureau,Guangdong Province,Guangzhou 510430,China |
|
|
|
|
Abstract Objective To analyze the clinical characteristics and medication characteristics of risperidone-induced extrapyramidal side effect(EPS).Methods The general data(sex,age,weight),medication methods(indications,dosage of medication,time of medication,combined medication)and clinical symptoms,treatment measures and outcome of 60 cases of Risperidone-induced EPS reported from Mental Hospital of Guangzhou Civil Affairs Bureau to the National Adverse Drug Reaction Monitoring Center from 2010 to 2019 were retrospectively analyzed.Results From the perspective of age distribution,among 60 adverse drug reaction(ADR)reports,the proportions of prime of life(41-50 years old),youth(21-30 years old)and middle-aged(31-40 years old)were relatively high,18%,17% and 13%,respectively.From the perspective of sex,the incidence of EPS caused by Risperidone was higher in female patients,which was 65.00%.According to the analysis of different types of tablets,the number of adverse reactions caused by oral tablets was the largest in 26 cases(43.33%),followed by orally disintegrating tablets of 24 cases(40.00%).From the dose analysis,when the daily dose of Risperidone was in the range of 4-6 mg,the risk of EPS was relatively high,and we did not observe the occurrence of EPS with a daily dose of 6 mg or more.From the perspective of the way of medication,there were more EPS in 39 cases(65.00%)when Risperidone was used alone.From the analysis of the time of occurrence,53.33% of the cases of EPS occurred within 1 month of medication,and 30.00% cases occurred within 10 days of medication.Among the 60 cases of EPS in this study,Parkinson′s syndrome was the main type(n=43,71.67%);increased muscle tone of the extremities(n=38,63.33%)was also common.After the occurrence of EPS,41.67% of the patients′ clinical symptoms subsided spontaneously as the treatment continued,11 patients improved after symptomatic treatment and dose reduction,and 7 patients needed to be replaced with other antipsychotic drugs.Conclusion The incidence of EPS caused by Risperidone is relatively high in middle-aged patients and mostly occurs within one month of medication.It is more likely to occur with a single medication.Symptomatic treatment and dose reduction can help alleviate the clinical symptoms of EPS.It is recommended to strengthen clinical monitoring of high-risk patients to avoid the occurrence of adverse reactions.
|
|
|
|
|
|
| [1] |
陈伟家，朱秀清，王占璋，等.412 例利培酮不良反应/事件的临床分析[J].中国临床药学杂志，2018，27（3）：191-194.
|
| [2] |
高宏强，尤加永，张建.精神分裂症患者应用利培酮导致的不良反应分析[J].海峡药学，2017，29（12）：267-268.
|
| [3] |
宋环霞.我院精神科住院患者药品不良反应报告分析[J].中国药物评价，2016，33（3）：168-171.
|
| [4] |
陈燕.对利培酮所致不良反应特点的分析[J].当代医药论丛，2020，18（1）：44-45.
|
| [5] |
姚鹏，张德伦，沈宁平，等.利培酮致不良反应142 例分析[J].中国药房，2014，25（4）：358-360.
|
| [6] |
肖逸丽，王汉光，高镇松，等.213 例抗精神病药物不良反应分析[J].中国医院药学杂志，2016，36（11）：930.
|
| [7] |
孙秀琪.利培酮口服液与片剂在治疗痴呆患者病理性行为中的临床差异性研究[J].中华灾害救援医学，2020，8（12）：709-711.
|
| [8] |
杨晓敏，张红霞，王慧芳，等.利培酮、奥氮平和喹硫平治疗未服药的精神分裂症患者的疗效和不良反应：1年自然观察研究（英文）[J].上海精神医学，2011，23（3）：137-147.
|
| [9] |
丁君君.不同剂量利培酮治疗首发精神分裂症疗效、安全性分析[J].中国现代药物应用，2019，13（23）：188-189.
|
| [10] |
宋海英.不同剂量的利培酮治疗精神分裂症的效果和安全性[J].当代医药论丛，2020，18（12）：106-108.
|
| [11] |
胡文文.利培酮用药不良反应相关因素分析[J].社区医学杂志，2017，15（7）：56-58.
|
| [12] |
骆明杰，孙兵.药物联合治疗精神分裂症的效果及不良反应[J].中国继续医学教育，2020，12（24）：151-153.
|
| [13] |
郭敏.阿立哌唑与利培酮治疗精神分裂症后抑郁的疗效及不良反应观察[J].临床医药杂志电子文献，2020，7（21）：156，158.
|
| [14] |
李晓波.精神分裂症患者利培酮血药浓度与不良反应的关系分析[J].中国民康医学，2016，28（2）：47-48.
|
| [15] |
陆林.沈渔邨精神病学[M].6 版.北京：人民卫生出版社，2017：847.
|
| [16] |
中华医学会.临床技术操作规范·精神病学分册[S].北京：人民军医出版社，2006：3-4.
|
| [17] |
曹娟，黄书才，戴媛媛，等.精神分裂症住院病人应用阿立哌唑致锥体外系症状的影响因素[J].安徽医药，2019，23（10）：2104-2107.
|
| [18] |
周秋娟，吴晓燕，陈颖，等.153 例利培酮致不良反应的文献分析[J].中国药物警戒，2014，34（6）：351-354.
|
| [19] |
陆晋军，徐佳，严叶良，等.利培酮用药不良反应相关因素评价[J].世界最新医学信息文摘，2019，19（105）：129，135.
|
|
|
|
